Near-total resolution of multicentric castleman disease by prolonged treatment with thalidomide [7]

American Journal of Hematology

Volumn 81, Issue 4, 2006, Pages 303-304

  Starkey, Cindi R ^a   Joste, Nancy E ^a   Lee, Fa Chyi ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 6; THALIDOMIDE;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CYTOKINE PRODUCTION; DETERIORATION; DOSE RESPONSE; FEMALE; HUMAN; LETTER; LYMPH NODE BIOPSY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SYMPTOMATOLOGY;

ANGIOGENESIS INHIBITORS; BIOPSY; FEMALE; GIANT LYMPH NODE HYPERPLASIA; HUMANS; LYMPH NODES; REMISSION INDUCTION; THALIDOMIDE; TIME FACTORS;

EID: 33645710911     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20538     Document Type: Letter

References (2)

1. Lee FC, Merchant SH. Alleviation of systemic manifestation of multicentric Castleman's disease by thalidomide. Am J Hematol 2003;73:48-53.
2. Fishman SJ, Feins NR, D'Amato RJ, Folkman J. Thalidomide for Crohn's disease. Gastroenterology 2000;119:596-602 (Letter).